Provided by Tiger Trade Technology Pte. Ltd.

Cognition Therapeutics, Inc

0.8912
-0.0688-7.17%
Volume:791.86K
Turnover:742.32K
Market Cap:84.75M
PE:-4.60
High:0.9876
Open:0.9800
Low:0.8900
Close:0.9600
52wk High:2.05
52wk Low:0.5501
Shares:95.09M
Float Shares:85.42M
Volume Ratio:2.06
T/O Rate:0.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1936
EPS(LYR):-0.3228
ROE:-83.76%
ROA:-78.18%
PB:2.57
PE(LYR):-2.76

Loading ...

Mar 30, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 15, 2022

Major Issues Report

8-K - Current report
Feb 01, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 10, 2022

Major Issues Report

8-K - Current report
Nov 18, 2021

Major Issues Report

8-K - Current report
Nov 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2021

Major Issues Report

8-K - Current report
Nov 03, 2021

Major Issues Report

8-K - Current report
Nov 02, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Oct 25, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Oct 14, 2021

Major Issues Report

8-K - Current report
Oct 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 04, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 10, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 20, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 29, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 29, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 29, 2021

Correspondence

CORRESP [Cover] - Correspondence